Recurrent lupus nephritis pathology in the kidney transplant may not appear the same as previous disease in the native kidney.

Approximately 1 in 10 patients with lupus nephritis eventually progresses to kidney failure. Longer remission may help prevent chronic kidney disease (CKD) onset.

Current treatment paradigms for lupus nephritis offer significant room for improvement, according to a presenter at the ...

The following is a summary of “2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and ...

New AURORA 1 Analysis: LUPKYNIS-Based Triple Immunosuppressive Therapy Yields Deep Proteinuria Reduction in Lupus Nephritis ...

Pregnant women with systemic lupus erythematosus (SLE) who experience cardiovascular events are at high risk for adverse outcomes.

ACR's full guidelines on screening, treatment and management of #lupusnephritis are now available and emphasize continuous ...

AbelZeta Pharma, Inc. ("AbelZeta" or the "Company"), a global clinical-stage biopharmaceutical company focused on discovery and development of innovative and proprietary cell-based therapeutic ...

Lupus nephritis frequently recurs in the transplanted kidney, sometimes without clinical signs. Lupus nephritis frequently recurs after kidney transplantation, and it may be clinically quiescent ...

A non-profit that supports lupus patients across the state is now asking Michiganders for some financial help. Members of the Michigan Lupus Foundation say they’re dealing ...

Zai Lab accelerates innovative drug launches in China through partnerships and expertise, targeting $1.5-$2B revenue by 2028.

DESTIN, Fla. — Despite new therapies and evolving research, lupus nephritis continues to present clinical and research challenges, according to a presenter at the Congress of Clinical ...